In performing host-defense functions, cells of the immune system become activated by soluble chemokine signals and must migrate through endothelial cell or solid tissue barriers to reach sites of inflammation or infection. Regulated adhesive interactions of immune cells with endothelium, extracellular matrix components, and cells of solid organs are critical control points of the overall immune response. Both the soluble chemokine and cell adhesion receptor-mediated migration signals must converge on common intracellular targets to engage the cell migration machinery. In this article, we focus on the role of focal adhesion kinase (FAK) and its homolog Pyk2 as cytoplasmic mediators of motility events in multiple cell types. we introduce the overall domain structure of the FAK and Pyk2 nonreceptor protein tyrosine kinases (prKs), highlight some of the signals that activate these prKs, and detail the molecules that functionally interact and signal transduction pathways that may mediate cell migration responses. Emphasis is placed on the knowledge gained from studies using FAK-null cells as a model system to decipher the role of this PTK in promoting cell motility. lntroduction Cells of the immune system sense and migrate toward gradients of environmental factors, an ability of paramountimportance to the maintenance of homeostasis and the regula-
tion of host-defense functions. Both soluble factors and immobilized extracellular matrix (ECM) proteins can trigger changes in cell shape or directed migration events; these cues have been termed chemotactic and haptotactic stimuli, respectively. For a cell to initiate The shear stress regulated interaction of selectins on the lymphocytes with specific endothelial cell oligosaccharide structures leads to a rolling of the cells along the vessel wall. Stimulation of the lymphocytes by a local gradient of chemokines results in activation of integrin receptors and a firm attachment of these cells to the endothelium. In addition, engagement of chemokine receptors is known to activate members of the focal adhesion kinase family (FAK, Pyk2). Immunoglobulin superfamily (IG) receptors also stimulate FAK tyrosine phosphorylation and lymphocyte transmigration through the endothelial layer. These studies support the hypothesis that FAK activation (FAK-P) may be important in the transmigration processes of the lymphocytes to sites of inflammation.
Lymphocyr",@ migration events, it must be able to both positively and negatively regulate adhesive interactions with either neighboring cells or matrix components in order to generate propulsive traction forces. In particular, leukocytes in the bloodstream have to interact with and traverse the endothelium, a process referred to as extravasation, before they can migrate to sites of inflammation (Fig. 1) . Some of the earliest stimuli affecting circulating T lymphocytes are generated by chemokine signals, and subsequent extravasation events are modulated by signals from the selectin and integrin family of transmembrane adhesion receptor proteins (reviewed in ref. 1). In addition, these activation events are augmented by the involvement of costimulatory receptors (reviewed inref .2). Like the T cell receptor (TCR), these cellsurface receptors do not possess intrinsic enzymatic activities. Therefore, they must function through the activation of other receptor-proximal signaling proteins.
Stimulation of Focal Adhesion Kinase and Pyk2 During T Cell Activation
In the case of the TCR, the earliest detectable biochemical event is the rapid activation of several protein-tyrosine kinases (PTKs) (J). Among the PTKs that constitute the receptorproximal components of TCR signaling are members of the Src family, the SyWZAP-7} family, the Csk family, and the focal adhesion kinase (F'AK) family (4) that comprises FAK and PykZ (5) (also named related adhesion focal tyrosine kinase (6), calctum-dependent protein tyrosine kinase (7), or cell adhesion kinase P (B)).In response to TCR stimulation, FAK and Pyk2 tyrosine phosphorylation occurs within 1 to 2 min (9-1 I ), andthis phosphorylation is augmented when cells are adherent on matrix proteins or when they are costimulated with antibodies to B l, P2, or B3 integrin receptors ( 12-15 ).
Recent evidence has emerged that the activity of FAK and Pyk2 can also be regulated by chemokine and G-protein-linked receptor activation events (reviewed in ref. l6).In human T cells, chemokines such as RANTES stimulate the tyrosine phosphorylation of FAK ( I7 ), whereas both RANTES stimulation and CCR5 receptor-mediated events enhance PykZ tyrosine phosphorylatton ( lB).
Whereas the biologic role for increased PykZ tyrosine phosphorylation is not well defined, evidence is accumulating that increased FAK tyrosine phosphorylation is closely linked to both haptotaxis and chemotaxis cell migration in multiple cell types. In activated T cells, FAK prominently redistribntes to the leading edge of the migrating cells (19), and costimulation of cells with antibodies to CD3 andCD2 potently stimulates both FAK tyrosine phosphorylation and cell migratton(20).Whereas mouse gene knockout studies have yielded important information with regard to the function of various signaling molecules in T cell responses (21) , the FAK gene knockout yielded an early embryonic lethal phenotype (embryonic d 8.5) priorto the development of thymocytes (22). Interestingly, introduction of fak+t-heterozygosity into a fyr-'-mouse background resulted in an impaired development of CD4*CD8* thymocytes with atrophy of the thymic cortex (23), suggesting a role for FAK in T cell developmental processes. More recent studies have been focused on deciphering the molecular mechanisms of the migratory abnormalities displayed by FAK-/-fibroblasts. We summarize herein the current understanding for the role of FAKin cell miqration thathas emersed from genetic, biochemical, as well as cell biologic studies in various adherent cell types. In addition, we give a perspective on the potential use of FAK as a target to inhibit abnormal cell migration events in pathologic settings.
Functional Domains of FAK
F'AK is a 116-kDa protein that is expressed in a variety of cell types (2a). The primary structure of FAK is characterized by a central kinase domain and large flanking N-and C-terminal sequences that do not contain either src-homology 2 (SH2) or SH3 domains (Fig. 2) . Within the N-terminal region, sequence similarities exist to band 4.I homology domains Q5 ). The C-terminus contains a focal adhesion targeting (F.A.T.) domain that functions autonomously in mediating FAK localizationto focal contact sites ( I6).Interestingly, the F.A.T. domain encompasses the binding sites for the integrin receptor binding proteins paxillin (26) and talin (27,28), implicating these two molecules in the recruitment of FAK to focal adhesions. In addition, two prolinerich stretches are located in the C-terminal region that have been shown to serve as binding sites for SH3 domain-containing proteins such as pl3gcas (29) or the Rho-GTPase activating protein, Graf (30) . A similar molecular architecture is conserved in Pyk2, which is highly expressed in hematopoietic cells and neurons (31 ).
On appropriate cell stimulation, FAK and PykZ become activated through undetermined mechanisms and become highly tyrosine phosphorylated on several sites in vivo. Integrin receptor activation promotes trAK tyrosine phosphorylation at more than six different tyrosine residues ( 3 2 ),and, in particular, phosphorylation of FAK at sites within the kinase domain leads to elevated F'AK kinase activity 
FAK-Mediated Signaling Events
Biochemical analyses of FAK have demonstrated that this PTK is important in facilitating integrin-initiated signaling events in multiple cell types (35, 36) .A key step in FAK activation events is the autophosphorylation atTyr-397 that leads to the recruitment of Src family kinases. Src kinases are then in a position to phosphorylate additional tyrosine residues on FAK or on FAK-associated proteins such as p13gcas. Src-mediated phosphorylation of FAK at Tyr-925 promotes the SH2-mediated binding of the small Grb2 adapter protein, which provides a direct link to the activation of the small G-protein Ras and the downstream ERK2/mitogen-activated protein kinase (MAPK) pathway (34). Either Src family PTK or FAK-mediated phosphorylation of pl3gcas (37) promotes the binding of the adapter proteins Nck and Crk to p 130cu', which. in turn. facilitate the activation of the cJun amino terminal kinase (JNK)/MAPK pathway (38) or the serine/threonine p2l-activated kinase ( I 6 ) .Indeed, it has been recently demonstrated that the JNIVMAPK pathway is activated in a FAK-dependent manner on adhesion of cells to fibronectin and that these signals are necessary for efficient cell-cycle progression events (39) and may also be involved in generating cell survival signals (a0) Fig.3 ). (43 ) . Moreover, it is likely that FAK connections to the ERK/JNK MAPKs are important for the generation of promigratory signaling events. ERK2/MAPK activity has been shown to be directed toward the phosphorylation of myosin light chain kinase, thereby directly modulating cell migration (44 ) , and ERK/JNK MAPK phosphorylation of transcription factors has been shown to affect gene transcription events of various metalloproteinases (45 ) . Treatment of ovarian cancer cells with antisense oligonucleotides to reduce F'AK expression resulted in the inhibition of integrin-stimulated metalloproteinase 9 gene transcription and a dramatic reduction in carcinoma cell migration through a basement membrane barrier (46) . These results support a role for FAK-mediated signaling events in the control of cell misration.
Promotion of Integrin-Mediated Haptotaxis Cell Migration by FAK
Further evidence for an important role for FAK in cell migration comes from several in vivo studies showing thatthe invasiveness and metastatic potential of human tumors is directly proportional to the level of FAK protein expression (47) .In cell culture, overexpression of FAK increases integrin-mediated haptotaxis cell migration ft\). Genetic support for FAK function in cell migration comes from the analy s i s of FAK-defi cient fibroblasts. FAK-/-mouse embryos die at embryonic d 8.5 in utero owing to defective mesodermal development, a phenotype that closely resembles the embryonic lethal phenotypes observed in both fibronectin-and integrin B1-deficient mice (49) . Interestingly, fibroblasts isolated from F'AK-/-embryos adhere to ECM substrates and form numerous focal contact structures. Therefore, FAK does not have an essential role in promoting cell adhesion or in the formation of focal contact structures, both events required for the initial generation of traction forces. FAK-/-fibroblasts possess a distinct rounded morphology and exhibit motility defects when analyzedin wound-healing or modified Boyden chamber migration assays ( 16). Because the gastrulation stage of embryonic development is a period of prominent cell motility events, the embryonic lethality of the FAK deficiency is likely connected to the required role of F'AK in the turnover or regulation of focal contact structures during migration events.
Despite their extensive similarities, reexpression of FAK but not Pyk2 in FAK-/-fibroblasts rescues the migration defects (50). Interestingly, FAK variants with a mutated Src SH2 binding site (FAKY397F), compromised kinase activity (FAK K454R), or altered proline-rich SH3 domain binding sequences (FAK PlI2l7l3A) only partially restore the haptotaxis response of FAK-/-cells (51).These results suggest that multiple protein-protein interactions with FAK are required for the initiation of integrin-stimulated migration events. In contrast to the local\zation of FAK to focal adhesions, Pyk2 exhibits a perinuclear distribution in trAK-deficient fibroblasts. These results support the hypothesis that subcellular localization of FAK and/or PykZ is an important prerequisite for the promotion of cell migration. Indeed, targeting of the N-terminal and kinase domain of Pyk2 to focal adhesions by fusing these sequences to the C-terminus of FAK (which encompasses the trAT domain) results in increased FAK-/-haptotaxis cell motility (unpublished results).
Additional support for FAK in mediating cell migration comes from studies employing a dominant negative approach to inhibit F'AK 298 function. The FAK-related nonkinase domain (FRNK) is the autonomously expressed C-terminal domain of FAK encompassing the proline-rich sequences and the F.A.T. domain (53) (trig. 2). Expression of FRNK interferes with cell spreading and cell migration and is accompanied by reduced tyrosine phosphorylation of FAK. Because FRNK localizes to focal adhesion sites, the dominant-negative effects of FRNK expression are presumably owing to the competitive displacement of FAK from focal contact sites. This hypothesis is supported by the finding that a point mutant of FRNK (L1034S) containing an amino acid substitution in the F.A.T. domain does not localize to focal contacts and does not inhibit cell migration events (51). Therefore, the expression of FRNK acts to inhibit the formation of an active FAK-mediated signaling complex.
Promotion of Chemotaxis Cell Motility by FAK
In addition to integrin-stimulated signals, soluble chemokine and growth factor signals also act as potent stimulators of cell migration. Because falr'-embryos fail to develop and because gastrulation is characterizedby complex morphogenic cell movements stimulated by both integrin and growth factor cues, we speculated that FAK may be a common receptor-proximal component ofboth haptotaxis and chemotaxis cell migration events. Using the F'AK-/-, trAK reexpressing, and wild-type p411+/+ fibroblasts, we found that FAKdeficient cells display a significantly reduced chemotaxis response to normally mitogenic concentrations of platelet-derived growth factor (PDGF), epidermal growth factor (EGF), and basic fibroblast growth factor (52). In the FAK-'-cells, growth factor receptorstimulated tyrosine phosphorylation events are normal. However, in FAK+/+ and FAKreexpressing cells, FAK can be detected in a complex with the activated PDGF or EGF receptors. Whereas Pyk2 is expressed in the FAK-/-cells, it does not detectably associate with the activated receptors. We have found that the FAK-growth factor receptor association involves the N-terminalband 4.1 homology domain of FAK, occurs within minutes after growth factor stimulation, and is most likely mediated by some type of intermediary bridging protein (Fig. 4) . Deletion of the first 100 amino acids from the FAK N-terminus (FAK d1-100) abolishes the association of FAK with activated growth factor receptors. More important, FAK has to be localized in a membrane-proximal position at focal adhesions to enter in a complex with the growth factor receptor in vivo, because expression of FRNK can inhibit the association (52) .
Regarding cell migration, the association of FAK with the growth factorreceptoris necessary for a motility response, because expression of FAK d1-100 does not promote chemotaxis in the FAK-/-cells. The finding that FAK is able to localize to focal contact sites via its C-terminal tr 4.T. domain, where it propagates integrin-initiated signals, and also is able to associate with growth factor receptors via its N-terminus, provides an intriguing molecular explanation for a longstanding observation: signals received via growth factor receptors and extracellular matrix adhesion receptors have to synergize to fully activate cellular responses. For example, suspended fibroblasts only weakly respond to growth factor stimulation when compared to cells attached to ECM proteins or anti-integrin antibodies. Note that FAK normally is dephosphorylated and inactive in suspended cells. However, if constitutively activated FAK is expressed in cells, they are able to respond to growth factor signals while in suspensron (43) . FAK therefore seems to constitute a molecular glue that links integrin and growth factor receptors and to provide a \.-/ nocarcinoma cells, antisense oligonucleotides directed toward human F'AK, but not control oligonucleotides, dramatically reduced both FAK expression and EGF-stimulated chemotaxis without affecting cell viability and EGF'-stimulated tyrosine phosphorylation events (unpublished results). In addition, cell invasion through a reconstituted basement membrane was impaired in the FAK antisense but not control oligonucleotide-treated carcinoma cells. An alternative approach takes advantage of the endogenous inhibitor of FAK, the C-terminal trRNK fragment. Expression of F'RNK in endothelial cells inhibits their migratory response in wound-healing assays (54) , and transient FRNK expression acts as apotent inhibitor of fibroblast haptotaxis and chemotaxis motility events (51,52). FRNK-trans-fected rat aortic smooth muscle cells display reduced chemotaxis in response to the growth factor PDGF-BB (unpublished results). This finding is significant because PDGF-BBstimulated migration of vascular smooth muscle cells from the media to the intima of arteries is thought to be an underlying mechanism in restenosis, a pathologic process that limits the success of angioplasty procedures. Therefore, in addition to FAK reduction by antisense treatment, FRNK expression in target cells could be an effective means of inhibiting FAK-promoted cell migration events.
Conclusion
We have focused on the signaling connections between FAK and a variety of cellsurface receptors. One of the best analogies to describe the role of FAK in cells is that it functions as a "scaffold" for the assembly of a signaling complex through the coordinated recruitment of other PTKs and adapter proteins. Because FAK functionally interacts with different classes of erowth factor and intesrin receptors, it is an important receptor-proximal position to modulate the molecular events controlling cell migration. When tools/inhibitors become available to modulate FAK in lymphocytes, the information gained from the study of FAK-deficient fibroblasts should be applicable to hematopoietic cells, in which FAK is activated by both chemotactic and haptotactic stimuli. Continued future efforts to determine and decipher both the upstream and downstream signaling connections to FAK will enhance our knowledge about the molecular mechanisms that regulate cell growth, shape, and migration. 
